The SIM-SOF Trial for Hepatitis C

NCT02168361 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Pegylated Interferon alfa-2b
DRUG: Simeprevir
DRUG: Ribavirin
DRUG: Sofosbuvir

Sponsor

Center For Hepatitis C, Atlanta, GA